Remove 2007 Remove 2010 Remove Data Remove Treatment
article thumbnail

Cannabis – The study that blew my mind

Cannabis Law Report

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency doi: 10.1182/BLOOD-2010-12-323824. Implications.

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Good Is Cannabis for Multiple Sclerosis (MS)?

Greencamp

For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist. What is multiple sclerosis? three days.

article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
article thumbnail

USA: Trials & Tribulations Of Cancer Patient Looking To Grow Own Medical Cannabis In The US

Cannabis Law Report

The 40-year-old northeast Pennsylvanian native was diagnosed with Hodgkin’s lymphoma in 2010. Within months he realized he was going to have to grow his own cannabis to cut down on the cost of treatment. He still recoils when recalling his experience with mainstream medical treatment. Mike Rubin lives on borrowed time.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ).